Lithium in the prevention of suicide in mood disorders: Updated systematic review and meta-analysis

BMJ (Online)

Volumn 347, Issue 7916, 2013, Pages

  Cipriani, Andrea ^a,b   Hawton, Keith ^b   Stockton, Sarah ^b   Geddes, John R ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LAMOTRIGINE; LIOTHYRONINE; LITHIUM; MAPROTILINE; MIANSERIN; NORTRIPTYLINE; OLANZAPINE; PHENELZINE; PLACEBO; QUETIAPINE; VALPROATE SEMISODIUM; LITHIUM DERIVATIVE; TRANQUILIZER;

ARTICLE; AUTOMUTILATION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; DEATH; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MOOD DISORDER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; MIDDLE AGED; PRESCHOOL CHILD; SELF-INJURIOUS BEHAVIOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; CHILD, PRESCHOOL; HUMANS; LITHIUM COMPOUNDS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF-INJURIOUS BEHAVIOR; SUICIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880125490     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f3646     Document Type: Article

References (38)

1. Kessler RC, Angermeyer M, Anthony JC, DE Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 2007;6:168-76. (Pubitemid 350047829)
2. Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011;377:2093-102.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
4. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012;379:1045-55.
5. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170:205-28. (Pubitemid 27117683)
6. Nordentoft M, Mortensen PB, Pedersen CB. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 2011;68:1058-64.
7. Department of Health. National suicide prevention strategy for England. Department of Health, 2002.
8. US Department of Health Human Services. National strategy for suicide prevention: goals and objectives for action. US Department of Health and Human Services, Public Health Service, 2001.
9. Saunders KE, Hawton K. The role of psychopharmacology in suicide prevention. Epidemiol Psichiatr Soc 2009;18:172-8.
10. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005;162:1805-19. (Pubitemid 41428610)
11. Perlis RH. Hard outcomes: clinical trials to reduce suicide. Am J Psychiatry 2011;168:1009-11.
12. Higgins JPT, Altman DG, Sterne JAC, eds. Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
13. National Institute for Health and Clinical Excellence. Self-harm: longer-term management. (Clinical guideline 133.) 2011. www.nice.org.uk/CG133.
14. Hawton K, Harriss L, Hall S, Simkin S, Bale E, Bond A. Deliberate self-harm in Oxford, 1990-2000: a time of change in patient characteristics. Psychol Med 2003;33:987-95. (Pubitemid 37009817)
15. Skegg K. Self-harm. Lancet 2005;366:1471-83.
16. Madge N, Hewitt A, Hawton K, de Wilde EJ, Corcoran P, Fekete S, et al. Deliberate self-harm within an international community sample of young people: comparative findings from the child & adolescent self-harm in Europe (CASE) study. J Child Psychol Psychiatry 2008;49:667-77. (Pubitemid 351713310)
17. Owens D, Horrocks J, House A. Fatal and non-fatal repetition of self-harm. Systematic review. Br J Psychiatry 2002;181:193-9. (Pubitemid 34983525)
18. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 2012;379:721-8.
19. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75. (Pubitemid 38594143)
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
21. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006;8:625-39. (Pubitemid 44567144)
22. Gonzalez-Pinto A, Mosquera F, Alonso M, López P, Ramírez F, Vieta E, et al. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord 2006;8:618-24. (Pubitemid 44567143)
23. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 2007;68:380-3. (Pubitemid 46506801)
24. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex and carbamazepine. J Affect Disord 2007;103:5-11. (Pubitemid 47445781)
25. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry 2006;163:41-7.
26. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998;316:61-6.
27. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-22. (Pubitemid 38419270)
28. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010;375:385-95.
29. Cipriani A, Smith K, Burgess S, Carney S, Goodwin G, Geddes J. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev 2006;(4):CD003492.
30. National Institute for Health and Clinical Excellence. Depression: the treatment and management of depression in adults (update) (Clinical guideline 90.) 2009. www.nice.org.uk/CG90.
31. Cipriani A, Barbui C, Butler R, Hatcher S, Geddes J. Depression in adults: drug and physical treatments. Clin Evid (Online) 2011;pii:1003.
32. Kovacsics CE, Gottesman II, Gould TD. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 2009;49:175-98.
33. Ernst CL, Goldberg JF. Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry 2004;12:14-41. (Pubitemid 38295894)
34. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999;156:181-9. (Pubitemid 29077107)
35. O'Donnell KC, Gould TD. The behavioral actions of lithium in rodent models: leads to develop novel therapeutics. Neurosci Biobehav Rev 2007;31:932-62. (Pubitemid 47299256)
36. Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry 2006;11:336-51.
37. Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am 2008;31:247-69. (Pubitemid 351551422)
38. Malhi GS, Tanious M. Optimal frequency of lithium administration in the treatment of bipolar disorder. Clinical and dosing considerations. CNS Drugs 2011;25:1-10.